Aetiology and Outcomes of Thrombocytopenia in Pregnancy: A Cross-Sectional Study in a University Hospital, India
European Medical Journal · 2022
DOI: 10.33590/emj/10015267 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift European Medical Journal, 2022. Verfasst von Sudha V. Hooli und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Thrombocytopenia (TCP) is the second most common haematological finding in pregnancy next to anaemia. It carries a risk for both the mother and the fetus, associated with substantial maternal or neonatal morbidity and mortality. However, a specific therapy, if instituted promptly, improves the outcome for affected patients and their offspring. In patients in India, TCP during pregnancy is an underexplored condition.
Objectives
To assess the aetiology of TCP in pregnancy and to assess the maternal outcomes of TCP in pregnancy. Methodology: The authors included a total of 133 patients in their third trimester (>32 weeks), with a platelet count
Zitieren
APA
Hooli, S. V., Shah, N., Shah, P., Suresh, S., & Sunil, B. S. (2022). Aetiology and Outcomes of Thrombocytopenia in Pregnancy: A Cross-Sectional Study in a University Hospital, India. European Medical Journal. https://doi.org/10.33590/emj/10015267
Vancouver
Hooli SV, Shah N, Shah P, Suresh S, Sunil BS. Aetiology and Outcomes of Thrombocytopenia in Pregnancy: A Cross-Sectional Study in a University Hospital, India. European Medical Journal. 2022. doi:10.33590/emj/10015267
BibTeX
@article{Hooli2022,
author = {Hooli, Sudha V. and Shah, Neelima and Shah, Prashant and Suresh, Shrradha and Sunil, Bali Sukeshani},
title = {Aetiology and Outcomes of Thrombocytopenia in Pregnancy: A Cross-Sectional Study in a University Hospital, India},
journal = {European Medical Journal},
year = {2022},
doi = {10.33590/emj/10015267}
}
EUVIMED